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ABSTRACT
In the present study, acute toxicity of methanolic root extract (MREt) of Rauwolfia serpentina (10 - 250 mg/kg) was observed in
terms of hypoglycemic activity and behavior pattern including sedation and mortality rate in different groups of normoglycemic wister
mice (6/group). Orally administrated MREt (10 to 60 mg/kg) was found non-sedative and showed hypoglycemic activity by reducing the
mean blood glucose level from 80 to 62 mg/dL after 30 min of administration while the doses (100-250 mg/kg) of same extract showed
sedation and mortality rate from 17 to 100% within 4 h. The value of median lethal dose (LD50) of MREt of R. serpentina was 141.25
mg/kg (log LD50 = 2.15 mg/kg) from graph plotted between log-doses verses probits. In oral glucose tolerance test, MREt (10, 30 and 60
mg/kg) showed significant hypoglycemic activity at 0, 30 and 60 min by deceasing blood glucose level ranging from 31- 65%, 39 - 49%
and 25 - 51% respectively compared to control and negative control (treated with 0.05% dimethylsulfoxide @ 1 mL/kg) groups. However,
MREt (100 mg/kg), though hypoglycemic from 0 to 120 min, induced slight sedation and mortality in experimental mice. The results
indicated that the MREt (10 - 60 mg/kg) was non-sedative and effective in lowering the blood glucose level in mice but showed lethal
effect in terms of sedation and mortality at doses ≥ 100 mg/kg. Therefore, MREt of R. serpentina in small doses can improve the glucose
tolerance either at pancreatic or extra-pancreatic level.
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INTRODUCTION
Diabetes is one of the most common metabolic disorders and has become an epidemic of 21st century of both
genders in developed and developing countries(1). The
overall prevalence of diabetes (type I & II) worldwide was
found 2.8% in the year 2000 and expected to increase up to
4.4% by the year 2030(2). Pakistan is also facing the same
situation(3). The conventional treatments of diabetes includes
insulin injections, oral hypoglycemic drugs, exercise, diet or
combination of these(4). Oral hypoglycemic drugs, besides
having effective and immediate therapeutic action, have
adverse effects and are also costly(5). Most of the people
belong to low-paid countries like India, Bangladesh and
Pakistan are used to taking extracts of medicinal plants
for the treatment of various diseases including diabetes as
prescribed by herbal healers or Hakims(6). Ethno-botanical
information indicates that more than 800 medicinal herbs
and plants have been used as traditional remedies for the
treatment of diabetes(7). Therefore, the plant kingdom has
* Author for correspondence. Tel: 92-21-99261300 Ext. 2289;
Fax: 92-21-99261340; E-mail: qureshi29@live.com

become a target for drug companies and research institutes
to discover new compounds that are potential anti-diabetic
drugs with few or no side effects(8).
The Rauwofia serpentina Benth belongs to the family
Apocynaceae. It is well-reported in the treatment of hypertension and many mental disorders in Ayurvedic and Western
medicines(9,10). Besides, previous researches of R. serpentina
from 1950 - 1960 showed its brief and almost incomplete
hypoglycaemic activity in diabetic patients(11), both normal
& diabetic hypertensive patients(12) and in anesthetized
cats(13). However, a well-described proof related to its hypoglycaemic and hypolipidemic activities in alloxan-induced
diabetic rats has been published in 2009 using a single
dose of methanolic root extract (MREt) of this plant(14).
Therefore the present study was aimed to evaluate the dosedependent hypoglycemic activity of MREt of R. serpentina
in overnight fasted normoglycemic mice by conducting oral
glucose tolerance test and determining its median lethal
dose (LD50). It was a therapeutic dose selection study which
could be employed in the second phase to conduct long-term
hypoglycemic activity in type I & II diabetic animal models.
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MATERIALS AND METHODS
I. Animals
Male wister albino mice (20 - 30 g) were purchased from
the breading house of Dow University of Health Sciences
(DUHS), Karachi and kept under usual management conditions in conventional animal house of the same University.
They were given standard laboratory diet with free access to
water ad libitum. During the course of experiment no physical stress was provided to animals. The present study was
approved by the Institutional Ethical Review Board (IERB)
of Dow University of Health Sciences (DUHS), Karachi in
June 2010.
II. Plant Material
Roots of R. serpentina were purchased from Hamdard
Dawakhana, Sadar, Karachi and identified by experts in
Botany Department, University of Karachi, Karachi-75270,
Pakistan (voucher specimen: KU/BCH/SAQ/02).
III. Glibenclamide
Glibenclamide (Daonil) was purchased from Sanofiaventis Pakistan Ltd. and used as positive control in a dose
of 5 mg/kg.
IV. Dimethyl Sulphoxide (DMSO)
DMSO of analytical reagent grade was purchased from
Fisher Scientific (UK) and 0.05% in distilled water was
used as vehicle for administering MREt of R.serpentina in
experimental test mice.
V. Preparation of Methanolic Root Extract (MREt)
Forty grams of ground powder of roots of R. serpentina
was extracted with methanol (1 L; 95%) overnight and filtered
through Whatman No.1 filter paper twice. The filtrate was
then concentrated at 40°C till dryness in a rotary vacuum
evaporator (Eyela-NE) to obtain a brown residue that was
referred as MREt(14). This procedure yielded 3 - 4% (w/w) of
the dry root. The MREt was stored in an airtight container in
refrigerator below 10°C until used.
VI. Acute Toxicity
Mice fasted overnight were randomly divided into eight
groups (6/group). A single dose of each of 10, 30, 60, 100, 150,
200 & 250 mg/kg of MREt of R. serpentina was separately
administrated orally to the mice in each group, whereas
six mice in control group were treated with distilled water
(1 mL/kg) orally. The mice in both test and control groups
were then allowed free access to food and water, and their
activity were observed over a period of 12 h for behavior
change (sedative or not) and mortality rate(15). In addition,

hypoglycemic activity was determined after 30 min in its
respective group with the help of glucometer (Optium Xceed,
Diabetes Monitoring system by Abbott).
VII. Determination of Median Lethal Dose (LD50)
LD50 of methanolic root extract of R. serpentina was
determined by graphical method(16).
VIII. Effect of MREt of R. serpentina on Glucose Tolerance
in Mice
Overnight fasted experimental mice were divided into
different groups (6/group) according the treatments such as
control group (distilled water @ 1 mL/kg), negative control
(0.05% DMSO @ 1 mL/kg), positive control (glibenclamide
@ 5 mg/kg) and test group. Test group was further subdivided into four groups according to doses of MREt of
R. serpentina at 10, 30, 60 and 100 mg/kg in 1 mL 0.05%
DMSO. Each group after receiving its respective treatment
orally was immediately administered with glucose load at
2 g/kg body weight from the same route. Blood glucose was
monitored from the tail vein of mice at 0, 30, 60, and 120 min
from each group with the help of glucometer. Percent blood
glucose change between control and test groups with different
treatments was calculated using the following formula.
% glycemic change = ( Gx – Go ) / Go X 100
Where Go = mean blood glucose levels of control group at
different time intervals, Gx = mean blood glucose levels of
groups treated with each of glibenclamide (positive control)
and different doses of MREt of R. serpentina at different
time intervals respective to control.
IX. Statistical Analysis
The results of present study are expressed as mean ± SD
and analyzed by student’s t-test (Graphpad Software, Quick
Calcs Online calculator for Scientists). The differences were
considered significant with p < 0.01, p <0.001 & p <0.0001.

RESULTS
I. Acute Toxicity and Median Lethal Dose (LD50) of MREt
of R. serpentina
The doses of MREt of R. serpentina from 10 to 60 mg/kg
were found non-sedative and exerted hypoglycemic activity
by reducing the mean blood glucose level from 80 to 62 mg/
dL in overnight fasted normoglycemic mice as compared
to the control group. The dose 100 mg/kg of MREt, though
found hypoglycemic, gave 17% mortality within 4 h of oral
administration. However, the doses of MREt at 150, 200
and 250 mg/kg showed acute toxicity by making animals
extremely sedative and giving 50, 83 and 100% mortalities,
respectively (Table 1). Therefore the value of median lethal
dose (LD50) of MREt of R. serpentina was determined as
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141.25 mg/kg (log LD50 = 2.15 mg/kg) from graph plotted
between log-doses verses probits.
II. Effect of MREt of R. serpentina on Glucose Tolerance in
Mice
MREt of R. serpentina at doses of 10, 30 and 60 mg/
kg and glibenclamide exerted significant hypoglycaemic
activity at 0, 30 and 60 min as compared with control and
negative groups (p < 0.01, p < 0.001 & p < 0.0001). Doses
of extract decreased blood glucose level in the ranges of 31 64.60%, 38.95 - 48.87% and 25 - 51.01%, respectively, from
0 to 60 min after oral glucose load (2 g/kg) as compared
with control group. Almost same hypoglycemic activity was

observed at 120 min after glucose load in control, negative
& positive controls and test groups. However, MREt in a
dose of 100 mg/kg was found hypoglycemic from 0 to 120
min after glucose load but induced slight sedation in experimental mice (Table 2).

DISCUSSION
Medicinal plants or herbs and their extracts from ancient
times have been used for the treatment of diseases such as
diabetes, hypertension, gastrointestinal and skin disorders,
with or negligible side effects(17). R. serpentina is a wellknown anti-hypertensive medicinal herb but it induces

Table 1. Acute toxicity of methanolic root extract (MREt) of R. serpentina
Treatments

Hypoglycemic activity*

Sedative behavior

% Mortality rate

Control (distilled water 1ml/kg)

119.33 ± 12.56

-

0

MREt of R.serpentina (10mg/kg)

80 ± 2.56*** (- 33)

-

0

MREt of R.serpentina (30mg/kg)

65 ± 1.23*** (- 45)

-

0

MREt of R.serpentina (60mg/kg)

62 ± 2.83*** (- 48)

-

0

MREt of R.serpentina (100mg/kg)

55± 3.56*** (- 54)

+

17

MREt of R.serpentina (150mg/kg)

26 ± 0.82*** (- 78)

++

50

MREt of R.serpentina (200mg/kg)

-

+++

83

MREt of R.serpentina (250mg/kg)
+++
100
* Blood glucose level (Mean ± SD) after 30 minutes of oral administration of distilled water in control and each dose of extract in test
groups. Values in parenthesis represent percent blood glucose decrease (-) compared to control group
*** = p< 0.0001 when compared with control group
- = No sedation was observed
+ = slightly sedative and 17% mortality was observed within 4 hours of administration of dose
++ = moderately sedative and 50% mortality was observed within 4 hours of administration of dose while other mice regain normal behavior
after providing diet and water
+++ = Acute toxicity (extremely sedative and 83-100 % mortality was observed)

Table 2. Effect of MREt of R.serpentina on glucose tolerance in mice
Groups

Treatments

Blood glucose level (mg/dL)
0 min

30 min

60min

120 min

distilled water (1 mL/kg) + glucose load (2 g/kg)

150 ± 26.33

252.3 ± 25.8

185.6 ± 17.62

92 ± 23.30

Negative control 0.05% DMSO (1 mL/kg) + glucose load (2 g/kg)

140 ± 25.16

250 ± 5.57

178.6 ± 8.02

98.6 ± 10.60

Positive control

96 ± 16.70**
(-36)

110.6 ± 6.66***
(-56.16)

85.3 ± 18.04 ***
(-54.04)

81 ± 10.44
(-11.95)

MREt (10 mg/kg) + glucose load (2 g/kg)

102.3 ± 23.71*
(-31.8)

89.3 ± 19.73***
(-64.60)

104 ± 15.72***
(-43.96)

94.3 ± 17.16
(+2.5)

MREt (30 mg/kg) + glucose load (2 g/kg)

84 ± 16.09**
(-44)

129 ± 0.22***
(-48.87)

113.3 ± 11.72***
(-38.95)

93.3 ± 8.02
(+1.41)

MREt (60 mg/kg) + glucose load (2 g/kg)

112 ± 7.21*
(-25)

123.6 ± 7.77***
(-51.01)

114.6 ± 9.07***
(-38.25)

100.6 ± 8.14
(+9.34)

MREt (100 mg/kg) + glucose load (2 g/kg)

86.6 ± 14.15**
(-42.2)

116.6 ± 40.38***
(-53.08)

109 ± 36.29**
(-47.27)

106.3 ± 12.01
(+15.54)

Control

glibenclamide (5 mg/kg) + glucose load (2 g/kg)

Test

*, ** & *** = p< 0.01, p< 0.001 & p<0.0001 when compared with respective control and negative control groups. All values are expressed as
mean ± SD (n=6). Values in parenthesis represent percent blood glucose decrease (-) / increase (+) compared with respective time interval in
control group.
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sedation by depleting the catecholamine in central nervous
system(9,10). Some studies have reported the hypoglycemic
activity of R. serpentina in hypertensive patients and in
anesthetized cats but with less elaborative manner. Recently
a single dose (30 mg/kg) of MREt of R. serpentina was
proved to have hypoglycemic and hypolipidemic activities
in alloxan-induced diabetic rats without affecting the serum
level of liver-specific enzyme alanine aminotransferase(14).
According to literatures, root bark of R. serpentina are
rich in alkaloids such as reserpine, ajmaline, etc(18,19). Hence
it is necessary to devise the effective dose of root extract of
this plant with respect to hypoglycemic effect because of its
sedative (antihypertensive) effect which could make it lethal
in higher doses. Therefore the present study for the first time
determined the median lethal dose (LD50) of MREt of R.
serpentina and demonstrated the hypoglycemic activity of
various doses (10 - 250 mg/kg) of same extract by conducting
oral glucose tolerance test in overnight fasted normoglycemic
mice. The experiment of acute toxicity proved that doses of
MREt at 10, 30 & 60 mg/kg were safe and hypoglycemic by
reducing the mean blood glucose level from 33 to 48% after
30 min administration as compared to control group while
doses of same extract from 100 to 250 mg/kg induced severe
hypoglycemia with sedation and mortality rate from 17% to
100% in mice within 4 h of administration.
The oral glucose tolerance test (OGTT) is designed to
evaluate the person’s ability to tolerate orally administrated
glucose and is well-known in diagnosis of pre-diabetic and
diabetic conditions(20). In addition, it is also used to diagnose
a malabsorption syndrome in which sugar is not properly
absorbed through intestines into the blood stream(4). In the
present study, doses of MREt extract of R. serpentina at 10,
30 and 60 mg/kg were found effective in reducing blood
glucose level after 0, 30 and 60 min of treatment (MREt +
glucose load) without being sedative in their respective test
groups. Three of these doses significantly decreased blood
glucose level by 25 - 65% at 0, 30 and 60 min after oral
administration in their respective test group as compared to
control and negative control groups. This decrease in blood
glucose level might be due to the extra-pancreatic action of
extract either by inhibiting glucose absorption in intestine
or by increasing glucose tolerance in mice by enhancing
the glucose uptake in tissues such as muscles and liver and
thereby stimulating glycolysis and hepatic glycogenesis(14).
Interestingly, the hypothetical mechanism of enhancing
glucose tolerance in mice has been proven by comparing the
values of blood glucose at 0 min in each of the group treated
with different concentrations (10, 30 and 60 mg/kg) of MREt
along with glucose load (2 g/kg) with respective control at the
same time which was only treated with distilled water and
glucose. However, almost the same levels of blood glucose
were found in all groups including control, negative & positive controls and test groups (MREt @10, 30, 60 mg/kg)
after 120 min of their respective treatment with glucose load
(2 g/kg). The MREt (100 mg/kg) induced sedation and 17%
mortality beside being hypoglycemic up to 120 min after its
administration along with glucose while the rest of the live

mice of this group regain normal behavior after feeding with
normal diet and water. The oral hypoglycemic agent glibenclamide (positive control) was also found significant in
increasing glucose tolerance in mice as compared to control
and negative control groups from 0 to 60 min (p < 0.001 &
p < 0.0001).
The glibenclamide, a second generation sulfonylureas
(known antidiabetic drug) which increases the release
of insulin from functional β-cells of pancreas(21). This
give another possible mechanism of action of MREt of R.
serpentina in reducing the blood glucose level by acting at
pancreatic level and enhancing the release of insulin which
in turn decrease blood glucose level by stimulating all the
anabolic effects(22). Some medicinal plants were reported to
enhance the release of insulin from beta-cells of pancrease
such as Gymnema sylvestre, Ocimum sanctum, Phyllanthus
species(23-26). MREt from 10 to 60 mg/kg did not severely
deplete the concentration of catecholamines in central
nervous system as no sedation was found in their respective
test groups. Therefore, MREt from 10 to 60 mg/kg could be
chosen for studying the long-term hypoglycemic activity in
type I and II diabetic animal models which will not only help
in elucidating the exact mechanism of action of the extract
in reducing blood glucose level but also in finding a new
bioactive compound with hypoglycemic activity.

CONCLUSIONS
The methanolic root extract of R. serpentina was effective in lowering the blood glucose level in doses from 10
- 60 mg/kg and induced no sedation in experimental mice
but showed lethal effect by inducing sedation and mortality
at doses from 100 - 250 mg/kg. Therefore 10, 30 & 60 mg/
kg doses have been selected to conduct a study concerning
long-term hypoglycemic activity in type I and II diabetic
animal models.
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